Nasdaq:US$19.70 (-0.20) | HKEX:HK$31.35 (-0.05) | AIM:£3.13 (-0.02)
Sustainability Reports

2023 Sustainability Report

1. ABOUT THIS REPORT 3
2. 2023 SUSTAINABILITY HIGHLIGHTS 4
3. MESSAGE FROM OUR CHAIRMAN 7
4. ABOUT HUTCHMED 9
5. SUSTAINABILITY GOVERNANCE 15
Sustainability Governance Structure
Risk Management
Sustainability & Governance Policies
6. SUSTAINABILITY STRATEGY 22
Stakeholder Engagement Approach
Developing a Holistic Sustainability Strategy
7. BUSINESS ETHICS & ANTI-CORRUPTION 30
Code of Conduct & Anti-Corruption
Employee Awareness; Anti-Corruption Training; Human Rights & Labor Rights
Data Privacy & Security; Intellectual Property
Whistleblowing
8. RESPONSIBLE COMMERCIALIZATION 35
Responsible Marketing & Pricing
Anti-Counterfeiting & Product Traceability
Adverse Events; Pharmacovigilance Quality
Responsible Supply Chain Management
9. RESEARCH & DEVELOPMENT 43
Our Innovative Approach
Clinical Trials
Conducting Safe & Ethical Clinical Trials
Disclosure of Clinical Data; Animal Welfare
Product Quality & Safety
10. ACCESS TO HEALTHCARE 51
Affordability & Access to Products & Healthcare
Patient Engagement & Advocacy
11. CLIMATE ACTION 55
Climate Resilience & Climate Action
Waste & Packaging
Water Use; Product Sustainability
12. HUMAN CAPITAL MANAGEMENT 64
Promoting Diversity, Equity & Inclusion
Talent Development & Engagement
Communication With Employees
Occupational Health & Safety
Community Investment
13A. PERFORMANCE DATA SUMMARY (ENVIRONMENTAL) 74
13B. PERFORMANCE DATA SUMMARY (SOCIAL) 78
14. NON-CONSOLIDATED JOINT VENTURE 83
15. REPORTING INDEX 85
1) HKEX, Nasdaq, LSE Group & GRI ESG Reporting Guides Content Index
2) SASB Content Index
3) TCFD Content Index
16. LIST OF ABBREVIATIONS 101

Previous Reports